LAX-TAB - Medsafe
LAX-TAB Bisacodyl Presentation Tablet: 5mg: sugar-enteric coated. Uses Actions LAX-TAB is a locally acting laxative from the triarylmethane group, which, after metabolism by
Download LAX-TAB - Medsafe
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
European versus United States Pharmacopeia Disintegration ...
www.dissolutiontech.comDissolution Technologies UUS 2015 7 MATERIALS AND METHODS Materials Uncoated size 4 oval placebo soft gelatin capsules were received as a gift from Catalent Pharma ...
United, States, European, Pharmacopeia, Versus, European versus united states pharmacopeia
A Brief Review of the FDA Dissolution Methods Database
www.dissolutiontech.comAUGUST 2016 7 suspensions, and ophthalmic and otic suspensions. However, methods for such dosage forms are rather rare (about 2.5% of the database content).
Methods, Review, Dissolution, Review of the fda dissolution methods
ADETPHOS KOWA Enteric Coated Tablet 20 ADETPHOS …
www.e-search.ne.jpKowa Co., Ltd. 1 Revised: September 2009 (7th version) Standard Commodity Classification No. of Japan 873992 - Metabolism Activator - ADETPHOS KOWA Enteric Coated Tablet 20 ADETPHOS KOWA Enteric Coated Tablet 60 ADETPHOS KOWA Granule 10% < ATP Product > DESCRIPTION
Tablets, Coated, Enteric, Wako, Adetphos kowa enteric coated tablet, Adetphos
GeloMyrtol 300 mg
www.gelomyrtol.caDear patient, Please read the following information for use carefully because it contains important information you should know when you use this drug.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET ASACOL Data Sheet 15 January 2018 Page 1 of 14 Emerge Health NZ Ltd 1 ASACOL Asacol 400mg enteric coated tablet Asacol 800mg enteric coated tablet Asacol 16.67% w/w suppository 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Sheet, Data, Coated, Zealand, New zealand data sheet, Enteric coated, Enteric
Enteric coating of ibuprofen tablets (200 mg) using an ...
www.scielo.brEnteric coating of ibuprofen tablets (200 mg) using an aqueous dispersion system 101 logies, Inc. Wayne, NJ) and Magnesium Stearate (FMC Corporation, USA) were used as directly compressible
Development of mesalazine pellets coated with methacrylic ...
www.scielo.brDevelopment of mesalazine pellets coated with methacrylic-derived polymer 105 ples from the same batches was carried out by a black and white CCD video camera (Biocam-VI-6633-China) atta-
Development, Coated, Pellet, Development of mesalazine pellets coated, Mesalazine
Enteric / Film Coat Capsules & Caplets intestine & colon ...
www.torpac.comEnteric coat for lower Enteric / Film Coat Capsules & Caplets intestine & colon drug release. Film coat for taste masking or appearance. ProCoater 1.3 1
Capsule, Coat, Film, Caplets, Enteric, Enteric film coat capsules amp caplets intestine, Intestine